Veterinarian placing slide onto scanner, ready for analysis using Vetscan Imagyst’s new AI Dermatology application.
Zoetis Introduces First-of-its-kind Artificial Intelligence (AI) Dermatology To Vetscan Imagyst™ Platform
11 months ago 
870 views
Zoetis Inc. has expanded its multi-purpose diagnostics platform, Vetscan Imagyst™, to include an application for AI dermatology - illustrating Zoetis’ pioneering role in redefining what is possible for in-clinic veterinary diagnosis and care across animal species. This diagnostic addition broadens the platform’s capabilities beyond existing AI canine and feline faecal analysis, AI blood smear analysis, and digital cytology applications, to include new in-clinic tests that are fully integrated into the company’s cloud-based artificial intelligence platform.
“The ability to accurately and reliably identify inflammatory cells, bacteria and yeast, at the time of visit can make a huge difference for busy clinics, ensuring better outcomes and happier patients and owners,” said Sophie Duguid, Diagnostics National Veterinary Manager at Zoetis UK. "Performing cytology is a critical component of the dermatology work-up, however this can often be challenging for veterinary healthcare teams to deliver given the considerable time pressures in clinical practice. Vetscan Imagyst AI dermatology allows clinicians to rapidly detect the presence or absence of skin infection in canine and feline dermatology cases which allows for clinically informed decision making."
Vetscan Imagyst AI Dermatology
Dermatology visits, especially with itch as the main presenting sign, are major reasons for veterinary visits.[i] With diagnosis and recommendation for treatment being made on the basis of presenting clinical signs and physical examination alone in 72% of cases1, the introduction of Zoetis’ Vetscan Imagyst AI dermatology application helps veterinary healthcare teams accurately diagnose and address dermatological concerns at the time of a pet’s visit. This addition expands the company’s dermatology portfolio, which has supported veterinarians in the management of pruritic dogs as a result of control of allergic itch with Apoquel® (oclacitinib tablet) and Cytopoint®.2
The Vetscan Imagyst AI dermatology application analyses impression smears as well as ear and skin swabs to identify yeast, inflammatory cells and bacteria. It then provides consistent and accurate results within minutes3, freeing up time for staff, patients and pet owners.
“Vets are often working in environments where time is of the essence, for patient outcomes and pet owner satisfaction, so access to AI dermatology analysis can really strengthen clinic performance,” said Adam Coomber, Marketing Manager at Zoetis UK. “Adding this application to the already multi-purpose Vetscan Imagyst displays Zoetis’ commitment to broadening its diagnostic expertise and providing cutting-edge technology to veterinary healthcare teams working across animal species.”
About Vetscan Imagyst, An All-in-One Technology
Launched in 2020, Vetscan Imagyst is a first-of-its-kind technology offering multiple applications in a single diagnostics platform, leveraging a combination of image recognition technology, algorithms and cloud-based AI. Using a compact scanner along with AI technology and backed by a global network of expert clinical pathologists, Vetscan Imagyst efficiently delivers a variety of consistent diagnostic tests and results. New applications, like AI dermatology will be easily integrated with existing Vetscan Imagyst testing capabilities, maximising clinic investment.
[1] Hill PB et al; Survey of the prevalence, diagnosis and treatment of dermatological conditions in small animals in general practice. Veterinary Record (2006) 158, 533-539
[2] Kynetec PetTrak – GAH-284: Unique Canine Patients Since Launch Custom Report: Apoquel and Cytopoint – September, 2022.
[3] Zoetis Data on File. Study Report No. D870R-US-22-053.
IMPORTANT SAFETY INFORMATION ABOUT APOQUEL® AND CYTOPOINT®
APOQUEL contains oclacitinib maleate. CYTOPOINT contains lokivetmab. POM-V.
For further information please see the products’ SPC or contact Zoetis UK Ltd, First floor Birchwood Building, Springfield Dr, Leatherhead, KT22 7LP www.zoetis.co.uk
More from Zoetis
- Zoetis appoints new Inside Sales Account Manager
- Zoetis Equip® Artervac Supply Issue
- Zoetis UK Appoints Simon Dunne as Companion Animal Business Unit Director
- Zoetis UK: Update On The Supply Of Equip® Rotavirus
- Zoetis UK and StreetVet Announce Charity of the Year Partnership to Further Support the Human Animal Bond
